205 results on '"Tijero, Beatriz"'
Search Results
2. Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study
3. Retinal thickness as a biomarker of cognitive impairment in manifest Huntington’s disease
4. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies
5. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
6. Autonomic nervous system education in Europe: EAN/EFAS/INUS survey on curricula and skills in autonomic medicine of European neurology residents and consultants.
7. Implication of nutrition in severity of symptoms and treatments in quality of life in Parkinson's disease: a systematic review.
8. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers
9. Heart-brain synchronization breakdown in Parkinson’s disease
10. Quantitative analysis of dysautonomia in patients with autonomic dysreflexia
11. Pearls and Oy-sters: Challenges and Controversies in Wilson Disease
12. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
13. Autonomic dysfunction is associated with neuropsychological impairment in Lewy body disease
14. Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers
15. Myocardial MIBG scintigraphy in genetic Parkinson’s disease as a model for Lewy body disorders
16. Brain Degeneration in Synucleinopathies Based on Analysis of Cognition and Other Nonmotor Features: A Multimodal Imaging Study
17. Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations
18. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene
19. Correction to: Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
20. Multimodal visual system analysis as a biomarker of visual hallucinations in Parkinson’s disease
21. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease
22. H35 Cognitive and neuropsychiatric differences between asymptomatic and symptomatic carriers of Huntington´s disease
23. Pearls & Oy-sters: Challenges and Controversies in Wilson Disease
24. Impact of Visual Impairment on Vision-Related Quality of Life in Parkinson’s Disease
25. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease
26. Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene
27. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy
28. Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies
29. Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies
30. Differences in visual-cognitive performance between asymptomatic and symptomatic carriers of Huntington’s disease (P3-11.002)
31. Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1)
32. Visual dysfunction is associated with cognitive impairment in Parkinson's disease
33. Autores
34. Factors influencing the symmetry of Parkinson's disease symptoms
35. Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson’s disease
36. Orthostatic Hypotension in Parkinson Disease: How Much You Fall or How Low You Go?
37. Application of depression criteria (DSM-IV) in patients with Parkinson's disease
38. Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related?
39. F15 Visual-cognitive impairment in asymptomatic and symptomatic carriers of huntington’s disease (HD)
40. Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project
41. Clinical long-term nocturnal sleeping disturbances and excessive daytime sleepiness in Parkinson's disease
42. Retinal thickness predicts the risk of cognitive decline in Parkinson's disease
43. Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project
44. Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson’s disease
45. Tako-tsubo cardiomyopathy in a patient with bilateral lesions in the dorsal medulla
46. Relationship between sleep and dysautonomic symptoms assessed by self-report scales
47. Retinal Thickness Predicts the Risk of Cognitive Decline in Parkinson Disease
48. Orthostatic hypotension associated with an epidermoid tumor of the IV ventricle
49. Restless legs syndrome in Parkinsonʼs disease
50. Seronegative and seropositive autoimmune autonomic ganglionopathy (AAG): Same clinical picture, same response to immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.